Key result
Cryoablation during rheumatic mitral surgery is linked to ~28 mL greater LA volume reduction vs RFA.
Why the study?
The comparative impact of radiofrequency ablation versus cryoablation on atrial remodeling during mitral valve surgery for rheumatic mitral valve disease with persistent AF remains uncertain.
Does cryoablation improve atrial reverse remodeling compared to radiofrequency ablation in patients with rheumatic mitral valve disease and persistent AF undergoing mitral valve surgery?
Cohort (n=100)
Yes
Does cryoablation improve atrial reverse remodeling compared to radiofrequency ablation in patients with rheumatic mitral valve disease and persistent AF undergoing mitral valve surgery?
Mean Difference: 27.88 (95% CI 15.15–40.61)
p-value: p=<0.0001
In patients with rheumatic mitral valve disease and persistent AF, concomitant cryoablation during mitral valve surgery may promote greater early left atrial reverse remodeling and better stroke volume preservation compared to radiofrequency ablation.
Cryoablation was associated with greater left atrial remodeling than radiofrequency ablation; leaves open outcome benefits and practice preference.
Background and aims Atrial fibrillation (AF) frequently accompanies rheumatic mitral valve disease (MVD) and adversely affects postoperative outcomes. Radiofrequency ablation (RFA) and cryoablation are commonly used during mitral valve surgery, but their comparative impact on atrial remodeling in this population remains uncertain. Methods This retrospective cohort included 100 patients with rheumatic MVD and persistent AF who underwent mitral valve surgery with concomitant cryoablation ( n = 50) or RFA ( n = 50) between June 2020 and June 2024 at centers in the Almaty region, Kazakhstan. Clinical and echocardiographic parameters were assessed preoperatively, within 48 h postoperatively, and at 6 ± 2 months. Results Cryoablation was associated with greater left atrial (LA) volume reduction immediately and at follow-up (both p < 0.001). Multiple linear regression identified ablation modality as the only independent predictor of LA volume reduction ( β = 27.9 mL, p < 0.0001), whereas duration of rheumatic disease, BMI, EuroSCORE II, and AF recurrence were not significant. At follow-up, the reduction in right atrial short-axis diameter was smaller after cryoablation ( p = 0.049), and stroke volume declined less compared with RFA (–1.2 ± 17.3 mL vs. −7.3 ± 15.8 mL; p = 0.006). Cardiopulmonary bypass time, aortic cross-clamp time, and postoperative symptom improvement were comparable between groups. Freedom from AF during follow-up was also similar (log-rank p = 0.52). Conclusions In patients with persistent AF and rheumatic MVD undergoing mitral valve surgery, cryoablation was associated with more pronounced early atrial reverse remodeling and better preservation of stroke volume compared with RFA, without differences in operative efficiency or short-term safety. These findings should be considered hypothesis-generating, and prospective randomized studies with standardized lesion sets are required to confirm modality-specific effects.
No takes yet. Share an insight, caveat, or question.
Nurbay et al. (2026) conducted a cohort in Rheumatic mitral valve disease with persistent atrial fibrillation (n=100). Cryoablation vs. Radiofrequency ablation was evaluated on Change in left atrial (LA) volume from baseline to 6-month follow-up (MD 27.88, 95% CI 15.15-40.61, p=<0.0001). Cryoablation during mitral valve surgery for rheumatic mitral valve disease resulted in a significantly greater reduction in left atrial volume (mean difference 27.88 mL) at 6 months compared to radiofrequency ablation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: